So several million more people are going to be prescribed statins but the vigorous campaign to inject some sanity into statin use has bought into sharp focus the conflict of interests at the heart of our health system.

One is whether the risks of these drugs when taken by healthy people actually outweigh the benefit? What we do know is that the only data on this comes from the manufacturers themselves. Think banks being the sole source of information about payment protection insurance or relying entirely on energy company data to choose the best tariff. (Read More…)

Next week we will learn […]